CU Anschutz Med Campus is a clinical research site located in Aurora, Colorado, United States 80045.
Crixeo Health Trust Score: 59/100 (POOR). This profile has not yet been claimed by the site owner.
CU Anschutz Med Campus has participated in 4 clinical trials with 3 currently active.
Therapeutic areas: Relapsing Multiple Sclerosis, Relapsing Multiple Sclerosis (RMS).
Sponsors: Novartis Pharmaceuticals.
Trust Score: 59/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
CU Anschutz Med Campus has a Crixeo Trust Score of 59/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
CU Anschutz Med Campus has 4 clinical trials on record, with 3 currently active. Their work covers Relapsing Multiple Sclerosis, Relapsing Multiple Sclerosis (RMS).
CU Anschutz Med Campus has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.